Literature DB >> 20080065

Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation.

Chisato Saeki1, Masanori Nakano, Hiroki Takahashi, Saburo Saito, Sadamu Homma, Hisao Tajiri, Mikio Zeniya.   

Abstract

Participation of Tregs in the generation of autoimmune hepatic inflammation (AHI) was examined using a newly established dendritic cell (DC)-based mouse model of hepatitis. The inflammatory activity of AHI peaked 21 days after DC vaccination. Forkhead box P3 (Foxp3) expression on day 21 was significantly increased in the liver but was decreased in the spleen. CD4(+)CD25(+) Tregs from the liver on day 21 showed inhibitory activity against the proliferation of CD4(+)CD25(-) T cells. On day 21, the expression of CXCR3 on Tregs and its ligand CXCL9 in hepatic tissue was upregulated, and levels of mRNA of transforming growth factor (TGF)-beta and IL-2, essential for Treg differentiation, in the liver were also increased. Suppression of AHI activity by prednisolone treatment decreased Treg accumulation in the liver. Accumulation of Tregs might occur through Treg recruitment mediated by CXCR3/CXCL9 interaction and expansion in the liver by upregulated TGF-beta and IL-2. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080065     DOI: 10.1016/j.clim.2009.12.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

Review 1.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

2.  Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver.

Authors:  Junaid Ibrahim; Andrew H Nguyen; Adeel Rehman; Atsuo Ochi; Mohsin Jamal; Christopher S Graffeo; Justin R Henning; Constantinos P Zambirinis; Nina C Fallon; Rocky Barilla; Sana Badar; Aaron Mitchell; Raghavendra S Rao; Devrim Acehan; Alan B Frey; George Miller
Journal:  Gastroenterology       Date:  2012-06-12       Impact factor: 22.682

Review 3.  Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Authors:  Muhammed Yüksel; Debby Laukens; Femke Heindryckx; Hans Van Vlierberghe; Anja Geerts; F Susan Wong; Li Wen; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2014-08-12       Impact factor: 1.925

4.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

5.  Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation.

Authors:  M Nakano; C Saeki; H Takahashi; S Homma; H Tajiri; M Zeniya
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

6.  Foxp3 expression in liver correlates with the degree but not the cause of inflammation.

Authors:  Matthaios Speletas; Nikoletta Argentou; Georgios Germanidis; Themistoclis Vasiliadis; Konstantinos Mantzoukis; Kalliopi Patsiaoura; Pavlos Nikolaidis; Vaios Karanikas; Konstantinos Ritis; Anastasios E Germenis
Journal:  Mediators Inflamm       Date:  2011-05-25       Impact factor: 4.711

7.  Protective Effect of CXCR3⁺CD4⁺CD25⁺Foxp3⁺ Regulatory T Cells in Renal Ischemia-Reperfusion Injury.

Authors:  Cao Jun; Li Qingshu; Wei Ke; Li Ping; Dong Jun; Luo Jie; Min Su
Journal:  Mediators Inflamm       Date:  2015-07-27       Impact factor: 4.711

8.  Hepatic stroma-educated regulatory DCs suppress CD8+ T cell proliferation in mice.

Authors:  Qian Wang; Hao He; Dongwei Chen; Chao Wang; Yingping Xu; Wengang Song
Journal:  Oncotarget       Date:  2017-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.